{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:01:43Z","timestamp":1777532503441,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jmmc-online.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.yjmcc.2015.05.019","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T12:29:04Z","timestamp":1433507344000},"page":"140-150","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7315-7402","authenticated-orcid":false,"given":"Oliver","family":"Adam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Hanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf W.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Klemmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Laufs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yjmcc.2015.05.019_bb0005","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0010","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00541464","article-title":"Torasemide, a new potent diuretic. Double-blind comparison with furosemide","volume":"31","author":"Broekhuysen","year":"1986","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0015","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","article-title":"Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure","volume":"111","author":"Murray","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0020","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1016\/j.jacc.2003.12.052","article-title":"Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure","volume":"43","author":"Lopez","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0025","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S1388-9842(02)00122-8","article-title":"Torasemide in chronic heart failure: results of the TORIC study","volume":"4","author":"Cosin","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0030","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0008-6363(02)00258-4","article-title":"Electrical, contractile and structural remodeling during atrial fibrillation","volume":"54","author":"Allessie","year":"2002","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/01.CIR.100.1.87","article-title":"Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort 1","volume":"100","author":"Li","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0040","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/CIRCEP.107.754564","article-title":"Atrial remodeling and atrial fibrillation: mechanisms and implications","volume":"1","author":"Nattel","year":"2008","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0045","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/415219a","article-title":"New ideas about atrial fibrillation 50years on","volume":"415","author":"Nattel","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0050","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1006\/jmcc.2002.2088","article-title":"Molecular mechanisms of myocardial remodeling. The role of aldosterone","volume":"34","author":"Delcayre","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0055","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2174\/1389450033490948","article-title":"Aldosteronism in heart failure: a proinflammatory\/fibrogenic cardiac phenotype. Search for biomarkers and potential drug targets","volume":"4","author":"Weber","year":"2003","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0060","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2003.05.003","article-title":"Additive improvement of left ventricular remodeling and neurohormonal activation by aldosterone receptor blockade with eplerenone and ACE inhibition in rats with myocardial infarction","volume":"42","author":"Fraccarollo","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0065","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cardiores.2005.03.001","article-title":"Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction","volume":"67","author":"Fraccarollo","year":"2005","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0070","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/eurheartj\/ehr266","article-title":"Aldosterone promotes atrial fibrillation","volume":"33","author":"Reil","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0075","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/01.LAB.0000059927.97515.FD","article-title":"Epidermal growth factor-induced epithelio-mesenchymal transition in human breast carcinoma cells","volume":"83","author":"Ackland","year":"2003","journal-title":"Lab Invest"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0080","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1253\/circj.67.384","article-title":"Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure","volume":"67","author":"Yamato","year":"2003","journal-title":"Circ J"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0085","doi-asserted-by":"crossref","first-page":"PL45","DOI":"10.1016\/S0024-3205(98)00265-3","article-title":"Torsemide inhibits aldosterone secretion in vitro","volume":"63","author":"Goodfriend","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0014-2999(91)90812-5","article-title":"Anti-aldosteronergic effect of torasemide","volume":"205","author":"Uchida","year":"1991","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0095","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jacc.2007.03.041","article-title":"Role of Rac1 GTPase activation in atrial fibrillation","volume":"50","author":"Adam","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.jacc.2009.08.064","article-title":"Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation","volume":"55","author":"Adam","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.yjmcc.2010.12.019","article-title":"Increased lysyl oxidase expression and collagen cross-linking during atrial fibrillation","volume":"50","author":"Adam","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0110","doi-asserted-by":"crossref","first-page":"H1","DOI":"10.1152\/ajpheart.00335.2010","article-title":"Role of lysyl oxidase in myocardial fibrosis. From basic science to clinical aspects","volume":"299","author":"Lopez","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1161\/HYPERTENSIONAHA.108.125278","article-title":"Impact of treatment on myocardial lysyl oxidase expression and collagen cross-linking in patients with heart failure","volume":"53","author":"Lopez","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0120","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0125","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s00395-012-0278-0","article-title":"Role of miR-21 in the pathogenesis of atrial fibrosis","volume":"107","author":"Adam","year":"2012","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0130","doi-asserted-by":"crossref","first-page":"6656","DOI":"10.1074\/jbc.M113.519256","article-title":"The mineralocorticoid receptor promotes fibrotic remodeling in atrial fibrillation","volume":"289","author":"Lavall","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0135","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cardiores.2006.04.005","article-title":"Association of RhoGDIalpha with Rac1 GTPase mediates free radical production during myocardial hypertrophy","volume":"71","author":"Custodis","year":"2006","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0140","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1172\/JCI8497","article-title":"Altered focal adhesion regulation correlates with cardiomyopathy in mice expressing constitutively active rac1","volume":"105","author":"Sussman","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0145","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/cvr\/cvq079","article-title":"Cardiac Rac1 overexpression in mice creates a substrate for atrial arrhythmias characterized by structural remodelling","volume":"87","author":"Reil","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0150","doi-asserted-by":"crossref","first-page":"6419","DOI":"10.1093\/nar\/17.15.6419","article-title":"Rapid detection of octamer binding proteins with \u2018mini-extracts\u2019, prepared from a small number of cells","volume":"17","author":"Schreiber","year":"1989","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0155","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1021\/jm800377h","article-title":"Overcoming undesirable CYP1A2 inhibition of pyridylnaphthalene-type aldosterone synthase inhibitors: influence of heteroaryl derivatization on potency and selectivity","volume":"51","author":"Heim","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0160","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1021\/jm800683c","article-title":"Novel aldosterone synthase inhibitors with extended carbocyclic skeleton by a combined ligand-based and structure-based drug design approach","volume":"51","author":"Lucas","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0165","doi-asserted-by":"crossref","first-page":"8077","DOI":"10.1021\/jm800888q","article-title":"In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivatives","volume":"51","author":"Lucas","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0170","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jsbmb.2009.04.013","article-title":"Selective aldosterone synthase inhibitors reduce aldosterone formation in vitro and in vivo","volume":"116","author":"Ries","year":"2009","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0175","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.bcp.2007.09.026","article-title":"Comparative effects of torasemide and furosemide in rats with heart failure","volume":"75","author":"Veeraveedu","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0180","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1073\/pnas.89.4.1458","article-title":"Role of steroid 11 beta-hydroxylase and steroid 18-hydroxylase in the biosynthesis of glucocorticoids and mineralocorticoids in humans","volume":"89","author":"Kawamoto","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0185","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1074\/jbc.273.9.4883","article-title":"Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation","volume":"273","author":"Silvestre","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0190","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0008-6363(99)00088-7","article-title":"Aldosterone and the heart: towards a physiological function?","volume":"43","author":"Delcayre","year":"1999","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0195","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1210\/jcem.86.11.7925","article-title":"Cardiac steroidogenesis in the normal and failing heart","volume":"86","author":"Young","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/cs1020381","article-title":"Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart","volume":"102","author":"Satoh","year":"2002","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0205","doi-asserted-by":"crossref","first-page":"e73737","DOI":"10.1371\/journal.pone.0073737","article-title":"The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes","volume":"8","author":"Gravez","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0210","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCULATIONAHA.110.983023","article-title":"Deletion of cardiomyocyte mineralocorticoid receptor ameliorates adverse remodeling after myocardial infarction","volume":"123","author":"Fraccarollo","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0215","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ijcard.2004.08.023","article-title":"Mechanisms of neurohormonal activation in chronic congestive heart failure: pathophysiology and therapeutic implications","volume":"101","author":"Davila","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrneph.2010.30","article-title":"Aldosterone: effects on the kidney and cardiovascular system","volume":"6","author":"Briet","year":"2010","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0225","doi-asserted-by":"crossref","first-page":"17718","DOI":"10.1074\/jbc.M512751200","article-title":"Nox1-dependent reactive oxygen generation is regulated by Rac1","volume":"281","author":"Cheng","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0230","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jacc.2012.12.043","article-title":"Dominance of furosemide for loop diuretic therapy in heart failure: time to revisit the alternatives?","volume":"61","author":"Bikdeli","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0235","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/j.jacc.2004.09.009","article-title":"Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure","volume":"44","author":"Tsutamoto","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0240","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ejphar.2007.11.034","article-title":"Torasemide, a long-acting loop diuretic, reduces the progression of myocarditis to dilated cardiomyopathy","volume":"581","author":"Veeraveedu","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0245","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.4238\/2014.September.5.11","article-title":"Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure","volume":"13","author":"Han","year":"2014","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0250","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.95.6.2979","article-title":"HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte","volume":"95","author":"Claycomb","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.yjmcc.2015.05.019_bb0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/ndt\/gfs388","article-title":"Aldosterone synthase inhibition in humans","volume":"28","author":"Azizi","year":"2013","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282815001790?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282815001790?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T00:35:57Z","timestamp":1537576557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282815001790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":51,"alternative-id":["S0022282815001790"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.05.019","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2015.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}